Yttrium-90 microspheres (TheraSphere®) treatment of unresectable hepatocellular carcinoma: Downstaging to resection, RFA and bridge to transplantation-Reference-Cited by-同舟云学术

Yttrium-90 microspheres (TheraSphere®) treatment of unresectable hepatocellular carcinoma: Downstaging to resection, RFA and bridge to transplantation

Published:2006 Issue:7 Volume:94 Page:572-586
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J. Surg. Oncol.

Author:

Kulik Laura M.,Atassi Bassel,van Holsbeeck Lodewijk,Souman Tameem,Lewandowski Robert J.,Mulcahy Mary F.,Hunter Russell D.,Nemcek Albert A.,Abecassis Michael M.,Haines Kenneth G.,Salem Riad

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Reference50 articles.

1. Cancer Facts & Figures 2004. American Cancer Society. Atlanta, ACS Pamphlet.

2. Extrahepatic manifestations of hepatitis C among United States male veterans

3. Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis

4. Liver transplantation for hepatocellular carcinoma: The MELD impact

Cited by 296 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Examining the Efficacy and Safety of Combined Locoregional Therapy and Immunotherapy in Treating Hepatocellular Carcinoma;Biomedicines;2024-06-27

2. Selective internal radiation therapy for unresectable HCC: The SIRT downstaging study;Hepatology Communications;2024-06-27

3. Comparing Laboratory Toxicity of Selective Intraarterial Radionuclide Therapy for Primary and Metastatic Liver Tumors: Resin versus Glass Microspheres;2024-05-29

4. Locoregional Therapies for Primary and Secondary Hepatic Malignancies;Cancer Treatment and Research;2024

5. SBRT vs. Y90;American Journal of Clinical Oncology;2023-11-20